IL15 and B-cell chronic lymphocytic leukemia: Moreover, the IL15 antibody-mediated stimulation of NK cells should be further investigated in the context of CLL pathology, including evaluation of whether leukemic cells are preserved by the IL15-mediated proliferating action [21], and in the context of CAR-NK cellular therapy for CLL.